首页 › 基金 › WYNNEFIELD CAPITAL INC › LFCR
WYNNEFIELD CAPITAL INC 对 LFCR 的持仓历史
LIFECORE BIOMEDICAL INC · 医疗保健
WYNNEFIELD CAPITAL INC 在 Q3 2026 的 13F 申报中披露持有 LFCR(LIFECORE BIOMEDICAL INC)4,867,816 股,市值约 US$32.0M,约占其申报组合的 26.30%,在其申报持仓中市值排名第 1 位。 WYNNEFIELD CAPITAL INC 最近 13 个申报季度中有 13 个季度披露了 LFCR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
WYNNEFIELD CAPITAL INC 对 LFCR 的持仓演变
WYNNEFIELD CAPITAL INC 于 Q3 2023 首次披露 LFCR 持仓:4,923,545 股(约 US$37.1M)。 该持仓在 Q4 2025 达到峰值 4,703,216 股,市值约 US$38.5M。 在 13 次申报中,WYNNEFIELD CAPITAL INC 1 次增持、1 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 4,867,816 股、市值约 US$32.0M,环比增持 164,600 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 4.92M | $37.15M | 新进 |
| Q4 2023 | 4.92M | $30.48M | 持有 |
| Q1 2024 | 4.92M | $26.14M | 持有 |
| Q2 2024 | 4.92M | $25.23M | 持有 |
| Q3 2024 | 4.92M | $24.25M | 持有 |
| Q4 2024 | 4.70M | $34.94M | 减持 |
| Q1 2025 | 4.70M | $33.11M | 持有 |
| Q2 2025 | 4.70M | $38.19M | 持有 |
| Q3 2025 | 4.70M | $34.62M | 持有 |
| Q4 2025 | 4.70M | $38.47M | 持有 |
| Q1 2026 | 4.70M | $17.50M | 持有 |
| Q2 2026 | 4.70M | $24.69M | 持有 |
| Q3 2026 | 4.87M | $32.03M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LFCR 与 13F 数据
LFCR(LIFECORE BIOMEDICAL INC)属于医疗保健行业。我们追踪的基金中还有 23 只申报持有 LFCR,申报仓位最大的包括:Legion Partners Asset Management, LLC (US$29.5M), 325 CAPITAL LLC (US$19.1M), Greenhaven Road Investment Management, L.P. (US$18.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LFCR 的基金
- Legion Partners Asset Management, LLC 4.48M 股 · $29.49M · Q3 2026
- 325 CAPITAL LLC 2.90M 股 · $19.05M · Q3 2026
- Greenhaven Road Investment Management, L.P. 2.87M 股 · $18.88M · Q3 2026
- DCF Advisers, LLC 376.50K 股 · $2.48M · Q3 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 305.31K 股 · $2.01M · Q3 2026
更多关于 WYNNEFIELD CAPITAL INC
常见问题
How long has WYNNEFIELD CAPITAL INC held LFCR?
WYNNEFIELD CAPITAL INC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is WYNNEFIELD CAPITAL INC's current position in LFCR?
As of Q3 2026, WYNNEFIELD CAPITAL INC holds 4.87M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $32.03M, representing 26.30% of its reported portfolio and ranking #1.
Has WYNNEFIELD CAPITAL INC been buying or selling LFCR?
In the latest 13F filing (Q3 2026), WYNNEFIELD CAPITAL INC increased its position in LFCR. The position peaked in Q4 2025 at 4.70M shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include Legion Partners Asset Management, LLC, 325 CAPITAL LLC, Greenhaven Road Investment Management, L.P., among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.